skip to main content
Language:

Effects of overactive bladder syndrome on female sexual function

Lin, Xiao-Dan ; Lin, Ning ; Ke, Zhi-Bin ; Xu, Ning ; Jiang, Ping ; Li, Hong

Medicine (Baltimore), 2021-05, Vol.100 (20), p.e25761 [Peer Reviewed Journal]

United States: Lippincott Williams & Wilkins

Full text available

Citations Cited by
  • Title:
    Effects of overactive bladder syndrome on female sexual function
  • Author: Lin, Xiao-Dan ; Lin, Ning ; Ke, Zhi-Bin ; Xu, Ning ; Jiang, Ping ; Li, Hong
  • Subjects: Adult ; Case-Control Studies ; Dyspareunia - drug therapy ; Dyspareunia - epidemiology ; Dyspareunia - etiology ; Female ; Humans ; Incidence ; Middle Aged ; Observational Study ; Orgasm ; Quality of Life ; Sexual Arousal ; Surveys and Questionnaires - statistics & numerical data ; Treatment Outcome ; Urinary Bladder, Overactive - complications ; Urinary Bladder, Overactive - drug therapy ; Urinary Bladder, Overactive - psychology ; Urological Agents - therapeutic use
  • Is Part Of: Medicine (Baltimore), 2021-05, Vol.100 (20), p.e25761
  • Description: This study was to evaluate the impact of the symptoms of overactive bladder (OAB) syndrome on female sexual function. Seventy nine patients with OAB (OAB group) and 79 healthy women (control group) underwent physical examination at our center, and had their sexual function evaluated using the female sexual function index (FSFI). In accordance with the presence or absence of urge incontinence, the OAB group was further divided into the wet and dry groups. The sexual function was evaluated again after 3 months of pharmacotherapy. We investigate the difference of sexual function between OAB and control group. The effect of OAB severity and OAB pharmacotherapy on sexual function was also explored. There were no significant differences between OAB group and control group, including age, body mass index (BMI), education, occupation, fertility, parity, childbirth, and menopause. Compared with the control group, the OAB group had significantly lower FSFI scores. The respective mean ± standard error FSFI scores in the control group and the OAB group were 2.98 ± 1.07 and 2.27 ± 0.96 for desire, 3.48 ± 1.16 and 2.32 ± 1.44 for arousal, 4.60 ± 1.13 and 3.10 ± 1.95 for lubrication, 3.37 ± 0.87 and 2.63 ± 1.04 for orgasm, 3.58 ± 1.02 and 2.41 ± 1.35 for sexual satisfaction, 3.58 ± 1.02 and 2.41 ± 1.35 for sexual pain, and 22.24 ± 5.29 and 15.59 ± 7.47 for the total score (P < .05 for all comparisons). The scores for desire, lubrication, orgasm, sexual satisfaction, pain, and total FSFI between the OAB-dry and OAB-wet subgroup were similar while score of arousal in OAB-wet subgroup was significantly increased compared with that of OAB-dry. OABSS score was commonly used in the assessment of OAB severity. The difference of the FSFI scores among mild OAB group, moderate OAB group, and severe OAB group was statistically significant (P < .05). Female FSFI sexual function scores were significantly improved after OAB pharmacotherapy (P < .05). Women with OAB syndrome have poorer sexual function than healthy women. Patients with more serious OAB experience more disturbing sexual dysfunction. Female sexual function scores were significantly improved after OAB pharmacotherapy.
  • Publisher: United States: Lippincott Williams & Wilkins
  • Language: English
Links
Back to results list
Go to Previous pagePrevious Result  8 NextGo to Next page

  • Implemented by: ABCD-USP USP   Social Network Logos: Freepik

Searching Remote Databases, Please Wait

  • Searching for
  • inscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
  • Show me what you have so far